Višnja Matković

905 Using chemotherapy response by KELIM score in patient with BRCA-mutated high-grade serous ovarian cancer to predict response to first line olaparib maintenance therapy: an one institution experience

Kristina Katić, Višnja Matković, Joško Lešin, Pavao Planinić et autres

hr (code pays fourni par la source)

Review of: "[Case Report] Clear Cell Carcinoma of the Ovary with Disseminated Intravascular Coagulation and Haemoperitoneum with Tumour Perforation"

Višnja Matković

The article is very interesting, but there are some missing data. It should be supplemented with the findings of the performed radiological processing before operation and laboratory findings in the perioperative course of the disease.

hr (code pays fourni par la source)

Review of: "[Case Report] Clear Cell Carcinoma of the Ovary with Disseminated Intravascular Coagulation and Haemoperitoneum with Tumour Perforation"

Višnja Matković

The article is very interesting, but there are some missing data. It should be supplemented with the findings of the performed radiological processing and laboratory findings in the perioperative course of the disease.

hr (code pays fourni par la source)

#760 Relationship between KELIM score and outcome of cytoreduction in patients with epithelial ovarian cancer undergoing neoadjuvant chemotherapy: an one institution experience

Kristina Katić, Višnja Matković, Joško Lešin, Goran Vujić

hr (code pays fourni par la source)

Comprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia

Dora Čerina, Višnja Matković, Kristina Katić, Ingrid Belac Belac Lovasić et autres

Today, in the era of precision medicine, the determination of genomic instability or other potentially targetable mutations, along with BRCA 1 and BRCA 2, is a crucial component of the diagnosis and treatment management of advanced ovarian cancer. Advanced technologies such as …

hr (code pays fourni par la source)

Clinical guidelines for diagnosis, treatment and monitoring of patients with ovarian cancer, Fallopian tube cancer and primary peritoneal can

Branka Petrić Miše, Višnja Matković, Ingrid Belac-Lovasić, Ana Fröbe et autres

11 Klinika za ženske bolesti i porode, Medicinski fakultet Sveučilišta u Splitu, Klinički bolnički centar Split, Split 12 Zavod za intervencijsku i dijagnostičku radiologiju, Medicinski fakultet Sveučilišta u Splitu, Klinički bolnički centar Split, Split Smjernice | Guidelines Deskriptori

hr (code pays fourni par la source)

Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus

Ana Fröbe, Blanka Jakšić, Višnja Matković, Herman Haller et autres

14 Medicinski fakultet Sveučilišta u Rijeci, Rijeka 15 Medicinski fakultet Sveučilišta u Splitu, Split 16 Hrvatsko katoličko sveučilište, Zagreb 17 Sveučilišni odjel zdravstvenih studija Sveučilišta u Splitu, Split Ove smjernice, njihovo drugo izdanje, napisane su za sve medicinske stručnjake koji sudjeluju u …

hr (code pays fourni par la source)

Clinical guidelines for diagnosis, treatment and monitoring of patients with cervical cancer

Anastazija Aleksandrova Stanojević, Vanda Paradžik Pašalić, Kristina Katić, Herman Haller et autres

Cervical cancer, in comparison with other gynecological malignancies, mainly affects younger women. It can be prevented through educational programs, vaccination, screening and early detection. In early stages it can also be effectively treated. Treatment modalities include surgery, radiotherapy and systemic therapy according …

hr (code pays fourni par la source)

Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice

Dora Čerina, Višnja Matković, Kristina Katić, Ingrid Belac-Lovasić et autres

Comprehensive genomic profiling (CGP) is gradually becoming an inevitable part of the everyday oncology clinical practice. The interpretation and optimal implementation of the results is one of the hot topics of modern-day oncology. According to the recent findings, uterine cancer harbors a …

hr (code pays fourni par la source)

Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients

Dora Čerina, Višnja Matković, Kristina Katić, Ingrid Belac-Lovasić et autres

Background. Although today it is almost preventable, cervical cancer still represents a significant cancer burden, especially in some developing parts of the world. Since the introduction of bevacizumab in the first-line treatment of metastatic disease, improvements of the outcomes were noted. However, …

hr (code pays fourni par la source)

Tolerability of bevacizumab in elderly patients with ovarian cancer: an experience from the Department of Gynecologic Oncology in the University Hospital Centre Zagreb

Kristina Katić, Višnja Matković, Joško Lešin, Goran Vujić et autres

Introduction: Bevacizumab is a recombinant humanized anti-VEGF monoclonal antibody.It is an effective treatment for epithelial ovarian cancer, both in primary and recurrent disease.The incidence of ovarian cancer increases with advancing age.Despite the high prevalence of the ovarian cancer in elderly, the management …

hr (code pays fourni par la source)

Uterine choriocarcinoma - a case report

Vanda Paradžik-Pašalić, Joško Lešin, Višnja Matković, Suzana Lide-Škalec

Choriocarcinoma is one of the histological types of entities called gestational trophoblastic neoplasia (GTN) that refers to a rare group of malignancies that are formed by abnormal proliferation of trophoblastic tissue.Choriocarcinoma is the most aggressive GTN histological type and is characterized by …

hr (code pays fourni par la source)